Loading clinical trials...
Loading clinical trials...
Novel Concepts for OnabotulinumtoxinA (Botox) Mechanisms of Action: Role in Altering the Molecular Environment in Which Pain Fibers Exist
Conditions
Interventions
Botulinum toxin type A
Locations
1
United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Start Date
December 1, 2017
Primary Completion Date
August 1, 2023
Completion Date
December 1, 2023
Last Updated
March 24, 2025
NCT06735833
NCT06241313
NCT06810505
NCT07071506
NCT07018713
NCT06641466
Lead Sponsor
Massachusetts General Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions